FDA Approves First Vaccine to Prevent Disease Caused by Chikungunya Virus

SILVER SPRING, Md., Nov. 9, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Ixchiq, the first chikungunya vaccine. Ixchiq is approved for individuals 18 years of age and older who are at increased risk of exposure to chikungunya virus. The chikungunya virus is…